In this report, the United States 3D Printing for Medical & Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of 3D Printing for Medical & Pharmaceuticals in these regions, from 2013 to 2025 (forecast).

United States 3D Printing for Medical & Pharmaceuticals market competition by top manufacturers/players, with 3D Printing for Medical & Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Arcam AB
3D Systems Inc.
Stratasys Ltd.
Cyfuse Biomedical K.K.
EOS GmbH Electro Optical Systems
Organovo Holdings
SLM Solutions Group AG
FabRx Ltd.
EnvisionTEC
Bio3D Technologies

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Surgical Guides
Implants
Surgical Instruments
Bioengineering
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Electron Beam Melting (EBM)
Stereolithography
Droplet Deposition Manufacturing

If you have any special requirements, please let us know and we will offer you the report as you want.